Patrick McIlvenny

Chief Accounting Officer, Horizon Therapeutics Public Ltd Co.

Companies

Horizon Therapeutics Public Ltd CoChief Accounting Officer Nov 14, 2022 to Oct 6, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Horizon Therapeutics Public Ltd Co0 shares²Oct 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 6, 2023Returned to company 6,874 shares at $116.50 of Horizon Therapeutics Public Ltd Co²
Jan 5, 2023Shares withheld for tax 4,147 shares at $113.24 of Horizon Therapeutics Public Ltd Co³
Jan 5, 2023Exercised options 7,973 shares of Horizon Therapeutics Public Ltd Co³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHorizon Therapeutics Public Ltd Co, Chief Accounting Officer
2
SEC EDGARHorizon Therapeutics Public Ltd Co shares after the filing of Oct 6, 2023
3
SEC EDGARForm 4 filed Jan 6, 2023